Similar periprosthetic joint infection rates after and before a national infection control program: a study of 45,438 primary total knee arthroplasties

被引:17
|
作者
Thompson, Olof [1 ]
W-Dahl, Annette [2 ,3 ]
Lindgren, Viktor [4 ]
Gordon, Max [5 ]
Robertsson, Otto [2 ,3 ]
Stefansdottir, Anna [3 ,6 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Infect Dis, Lund, Sweden
[2] Swedish Knee Arthroplasty Register, Lund, Sweden
[3] Lund Univ, Dept Clin Sci Lund, Div Orthoped, Lund, Sweden
[4] Karolinska Inst, Dept Mol Med & Surg, Sect Orthoped, Stockholm, Sweden
[5] Karolinska Inst, Div Orthoped, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden
[6] Skane Univ Hosp, Dept Orthoped, Lund, Sweden
关键词
TOTAL HIP-ARTHROPLASTY; REGISTER; MICROBIOLOGY; ASSOCIATION; RISK;
D O I
10.1080/17453674.2021.1977532
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and purpose - Strenuous efforts to minimize postoperative infection rates have been made, including the Swedish nationwide initiative Prosthesis Related Infections Shall be Stopped (PRISS). This study calculated the incidence rate of periprosthetic joint infection (PJI) following primary total knee arthroplasty (TKA) before and after PRISS. Patients and methods - All 45,438 primary TKAs registered in the Swedish Knee Arthroplasty Register (SKAR) during 2007-2008 and 2012-2013 were included. Matched data on antibiotic prescriptions were obtained from the Swedish Prescribed Drug Register (SPDR). All patients with >= 28 days of continuous antibiotic treatment within 2 years of primary surgery had their medical charts reviewed to identify cases of PJI. The incidence rate was calculated by dividing the number of PJIs by the total time at risk during each time period and presented as percentages with 95% confidence interval (CI). Results - 644 PJIs were identified, equaling a 2-year incidence rate of 1.45% (CI 1.34-1.57). The incidence rate was 1.44% (CI 1.27-1.61) before PRISS and 1.46% (CI 1.31-1.61) after. Diagnosis was made within 30 days of primary TKA in 52%, and within 90 days in 73% of cases. 603 cases were reoperated on or revised. Median time from operation to diagnosis was 29 days (1-716), for both time periods. Debridement with exchange of the insert was performed in 32% and 63% of cases before and after PRISS, respectively. Interpretation - We found similar incidence rates before and after the PRISS initiative without any statistically significant difference. Time to diagnosis was similar during both time periods. The project may have contributed to increased compliance with treatment protocols.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [21] Periprosthetic Joint Infection Risk After Primary Total Knee Arthroplasty: Are All Preoperative Corticosteroid Injections the Same?
    Muffly, Brian T.
    Ayeni, Ayomide M.
    Jones, Corey A.
    Heo, Kevin Y.
    Guild, George N.
    Premkumar, Ajay
    JOURNAL OF ARTHROPLASTY, 2024, 39 (05): : 1312 - 1316.e7
  • [22] Synovial Calprotectin for Diagnosing Periprosthetic Joint Infection in Loose Hip and Knee Arthroplasties: A Prospective Cohort Study
    Lazic, Igor
    Stephan, Maximilian
    Pohlig, Florian
    Langer, Severin
    Von Eisenhart-rothe, Rudiger
    Suren, Christian
    IN VIVO, 2023, 37 (04): : 1714 - 1720
  • [23] The Effect of Implementing a Multimodal Approach on the Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty
    Ko, Laura J. Matsen
    Yoo, Joanne Y.
    Maltenfort, Mitchell
    Hughes, Amy
    Smith, Eric B.
    Sharkey, Peter F.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (02): : 451 - 455
  • [24] Risk factors for periprosthetic joint infection after primary artificial hip and knee joint replacements
    Guo, Heng
    Xu, Chi
    Chen, Jiying
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (06): : 565 - 571
  • [25] Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection
    Nodzo, Scott R.
    Boyle, Keely K.
    Spiro, Sara
    Nocon, Allina A.
    Miller, Andy O.
    Westrich, Geoffrey H.
    KNEE, 2017, 24 (05): : 1175 - 1181
  • [26] Periprosthetic Joint Infection After Total Knee Arthroplasty With or Without Antibiotic Bone Cement
    Leta, Tesfaye H.
    Lie, Stein Atle
    Fenstad, Anne Marie
    Lygre, Stein Hakon L.
    Lindberg-Larsen, Martin
    Pedersen, Alma B.
    W-Dahl, Annette
    Rolfson, Ola
    Bulow, Erik
    van Steenbergen, Liza N.
    Nelissen, Rob G. H. H.
    Harries, Dylan
    de Steiger, Richard
    Lutro, Olav
    Makela, Keijo
    Venalainen, Mikko S.
    Willis, Jinny
    Wyatt, Michael
    Frampton, Chris
    Grimberg, Alexander
    Steinbrueck, Arnd
    Wu, Yinan
    Armaroli, Cristiana
    Gentilini, Maria Adalgisa
    Picus, Roberto
    Bonetti, Mirko
    Dragosloveanu, Serban
    Vorovenci, Andreea E.
    Dragomirescu, Dan
    Dale, Havard
    Brand, Christian
    Christen, Bernhard
    Shapiro, Joanne
    Wilkinson, J. Mark
    Armstrong, Richard
    Wooster, Kate
    Hallan, Geir
    Gjertsen, Jan-Erik
    Chang, Richard N.
    Prentice, Heather A.
    Sedrakyan, Art
    Paxton, Elizabeth W.
    Furnes, Ove
    JAMA NETWORK OPEN, 2024, 7 (05) : E2412898
  • [27] Rate and Risk Factors for Periprosthetic Joint Infection Among 36,494 Primary Total Hip Arthroplasties
    Triantafyllopoulos, Georgios K.
    Soranoglou, Vasileios G.
    Memtsoudis, Stavros G.
    Sculco, Thomas P.
    Poultsides, Lazaros A.
    JOURNAL OF ARTHROPLASTY, 2018, 33 (04): : 1166 - 1170
  • [28] Single-stage revision for chronic periprosthetic joint infection after knee and hip arthroplasties: indications and treatments
    Wenbo Mu
    Baochao Ji
    Li Cao
    Arthroplasty, 5
  • [29] Single-stage revision for chronic periprosthetic joint infection after knee and hip arthroplasties: indications and treatments
    Mu, Wenbo
    Ji, Baochao
    Cao, Li
    ARTHROPLASTY, 2023, 5 (01)
  • [30] SCOTLAND'S BUDGETARY IMPACT ASSOCIATED WITH IMPROVED DIAGNOSIS OF PERIPROSTHETIC JOINT INFECTION IN REVISION TOTAL HIP AND KNEE ARTHROPLASTIES
    Stonadge, J.
    Dunlop, S.
    McCormack, M.
    Cogswell, G.
    VALUE IN HEALTH, 2019, 22 : S246 - S246